Our previous data found that CCR6+Foxp3+ regulatory T cells were dominantly enriched in tumor mass and closely related to poor prognosis of breast cancer patients [14], to further investigate the mechanism of the enrichment of this tumor-resident Treg subset, the frequency of CCR6+ Tregs in TILs during tumor progression was observed. This evidence concerns the gene FOXP3 and breast carcinoma.